Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 15/20 | 0.49 |
| ▸ | CA2 | P00918 | 15/20 | 0.49 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22999805 | 0.83 | KDM4E (0.60) | KDM4ELMNAALOX15TSHRACMSD | |
| SCHEMBL19151497 | 0.78 | KDM4E (0.62) | KDM4ELMNAALOX15TSHRACMSD | |
| SCHEMBL17868449 | 0.78 | KDM4E (0.50) | KDM4ELMNAALOX15TSHRACMSD | |
| SCHEMBL3117402 | 0.74 | KDM4E (0.68) | KDM4ELMNAALOX15TSHRACMSD | |
| SCHEMBL19347972 | 0.74 | KDM4E (0.62) | KDM4ELMNAALOX15TSHRACMSD | |
| SCHEMBL30951916 | 0.74 | KDM4E (0.68) | KDM4ELMNAALOX15TSHRACMSD | |
| Dipicolinic Acid SCHEMBL34595 | 0.72 | KDM4E (1.00) | KDM4ELMNAALOX15TSHRACMSD | |
| Dipicolinic Acid SCHEMBL720696 | 0.72 | KDM4E (1.00) | KDM4ELMNAALOX15TSHRACMSD | |
| SCHEMBL22455532 | 0.71 | KDM4E (0.64) | KDM4ELMNAALOX15TSHRACMSD | |
| SCHEMBL19151675 | 0.71 | KDM4E (0.64) | KDM4ELMNAALOX15TSHRACMSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | disclosed |
| WO-2023111350-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | CA9, CA13, CA4 | KDM4E 2877/4885LMNA 2986/4885ALOX15 3405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.